Table 1.
The ranking of compounds from Glide docking and their calculated MM/GBSA binding energies (kcal/mol) using Prime of substituted pyrimidines and pteridinones in the ATP-binding site of the NTKD of RSK2. Inhibitory activity of compounds in the TR-FRET kinase assay against RSK2 (methods described in Casalvieri et al., 2020) given as the half-maximal inhibitory concentrations (IC50) or percentage inhibition; values are the mean ± S.D. (n = 3).
| Compound | Rank from Glide output | Dock Score | Calculated MM/GBSA binding energy (kcal/mol) | RSK2 Inhibition |
|---|---|---|---|---|
| BI-D1870 R-isomer | 2 | −10.6 | −86.3 | 23.3 ± 8.2 nM |
| BI-D1870 S-isomer | 7 | −10.1 | −79.9 | |
| BI-D1870 R-isomer deprotonated | 40 | −7.0 | −61.8 | |
| BI-D1870 S-isomer deprotonated | 43 | −6.8 | −57.5 | |
| BI-D1870 R-isomer protonated | 55 | −1.3 | −31.5 | |
| BI-D1870 S-isomer protonated | 54 | −1.3 | −27.3 | |
| 24R-isomer | 6 | −10.1 | −80.8 | 71% @ 10 μM |
| 24S-isomer | 16 | −9.7 | −83.0 | |
| 25R-isomer | 29 | −8.0 | −63.4 | 43% @ 10 μM |
| 25S-isomer | 35 | −7.3 | −67.1 | |
| 26R-isomer | 48 | −5.7 | −69.0 | 739 ± 14.1 nM |
| 26S-isomer | 30 | −8.0 | −67.9 | |
| 27R-isomer | 24 | −8.6 | −80.8 | 54.8 ± 1.4 nM |
| 27S-isomer | 28 | −8.1 | −76.5 | |
| 28R-isomer | 10 | −10.0 | −82.4 | 25.4 ± 3.2 nM |
| 28S-isomer | 17 | −9.4 | −74.6 | |
| 28R-isomer protonated | 57 | −0.6 | −31.7 | |
| 28S-isomer protonated | 58 | −0.6 | −25.2 | |
| 29R-isomer | 18 | −9.3 | −85.1 | 71.5 ± 10.3 nM |
| 29S-isomer | 22 | −8.7 | −78.1 | |
| 30R-isomer | 20 | −8.8 | −80.7 | 141 ± 25.7 nM |
| 30S-isomer | 23 | −8.6 | −80.9 | |
| 31R-isomer | 11 | −9.9 | −90.7 | 83% @ 10 μM |
| 31S-isomer | 31 | −7.9 | −78.1 | |
| 31R-isomer deprotonated | 39 | −7.0 | −69.4 | |
| 31S-isomer deprotonated | 32 | −7.9 | −66.1 | |
| 31R-isomer protonated | 50 | −2.8 | −56.5 | |
| 31S-isomer protonated | 51 | −2.8 | −45.1 | |
| 32R-isomer | 36 | −7.2 | −69.0 | 78% @ 10 μM |
| 32S-isomer | 25 | −8.4 | −78.2 | |
| 32R-isomer deprotonated | 37 | −7.1 | −74.5 | |
| 32S-isomer deprotonated | 27 | −8.1 | −71.8 | |
| 32R-isomer protonated | 49 | −3.1 | −60.6 | |
| 32S-isomer protonated | 52 | −2.7 | −47.5 | |
| 33R-isomer | 5 | −10.3 | −80.3 | 18.2 ± 1.4 nM |
| 33S-isomer | 4 | −10.3 | −81.1 | |
| 33R-isomer deprotonated | 26 | −8.4 | −60.5 | |
| 33S-isomer deprotonated | 42 | −6.9 | −53.6 | |
| 33R-isomer protonated | 53 | −2.0 | −25.1 | |
| 33S-isomer protonated | 41 | −7.0 | −48.1 | |
| 34 | 1 | −10.8 | −81.3 | 17.6 ± 1.4 nM |
| 34 deprotonated | 21 | −8.8 | −69.9 | |
| 35 | 12 | −9.9 | −77.1 | 38.3 ± 7.9 nM |
| 35 deprotonated | 34 | −7.3 | −50.5 | |
| 36 | 3 | −10.5 | −81.8 | 23.4 ± 4.7 nM |
| 37 | 15 | −9.8 | −76.9 | 24.7 ± 1.8 nM |
| 38 | 14 | −9.8 | −54.0 | 45% @ 10 μM |
| 38 deprotonated | 44 | −6.6 | −28.9 | |
| 39R-isomer | 8 | −10.0 | −66.5 | 83% @ 10 μM |
| 39S-isomer | 9 | −10.0 | −66.7 | |
| 39R-isomer deprotonated | 33 | −7.6 | −58.5 | |
| 39S-isomer deprotonated | 38 | −7.1 | −58.7 | |
| 43 | 13 | −9.8 | −58.9 | 72% @ 10 μM |
| 43 deprotonated | 46 | −6.2 | −34.5 | |
| 44 | 19 | −9.0 | −53.2 | 38% @ 10 μM |
| 44 deprotonated | 45 | −6.2 | −29.4 | |
| 44 protonated | 47 | −5.9 | −21.7 | |
| 44 deprotonated/protonated | 56 | −0.7 | −0.1 |